Speaking of dosage, in most clinical trials, you’ll see CBD dosing ranges from 10-800 mg of CBD per day (although to treat schizophrenia, I’ve seen doses as high as 1,300mg). But as with everything from whey protein to creatine to magnesium, everyone is different and you’ll likely need to experiment with a dosage range that works for you. The CBD capsules I personally use contain 10mg in one capsule, but based on the absorption (an important variable which you’re going to learn about next), I need to use far less CBD, about 1/10 the amount, compared to other CBD tinctures, extracts and capsules I’ve tried.
As noted, CBD has been found to have a bell-shaped response curve, with higher doses being ineffective. This may reflect activation of TRPV1 receptors at higher dose, as blockade of TRPV1 receptors in the DPAG rendered a previously ineffective high dose of CBD as anxiolytic in the EPM [66]. Given TRPV1 receptors have anxiogenic effects, this may indicate that at higher doses, CBD’s interaction with TRPV1 receptors to some extent impedes anxiolytic actions, although was notably not sufficient to produce anxiogenic effects.
capsules. Tinctures are offered in concentrations of 100 mg, 250 mg, 350mg, 550 mg, 30 ml, 1000 mg, or 1500 mg of crystalline CBD isolates and a broad spectrum of phytocannabinoids. The company’s capsules have a strength of 25 mg CBD, and contain 10% Broad-Spectrum CBD oil 10%, Cannabidiol hemp oil, Safflower oil, and Vegetable cellulose. Another product we recommend for anxiety is their loose-leaf Organic Chamomile CBD Tea. Chamomile has established calming and stomach-soothing effects, and is often used to promote restful sleep. In conjunction with CBD, this botanical contributes to a great product for anxiety-related insomnia. The tea contains 55 mg of CBD, Organic chamomile loose leaf tea, flowers and powder, vanilla, peppermint, and agricultural hemp.
Cannabinoids affect the transmission of pain signals from the affected region to the brain (ascending) and from the brain to the affected region (descending). A 2011 study showed that CBD and CBC stimulated descending pain-blocking pathways in the nervous system and caused analgesia by interacting with several target proteins involved in nociceptive control. Authors concluded that the cannabinoids “might represent useful therapeutic agents with multiple mechanisms of action.” [387] The following year, researchers reported that CBD significantly suppressed chronic inflammatory and neuropathic pain without causing apparent analgesic tolerance in animals. [388] And then in 2013, researchers concluded that chronic pain patients prescribed hydrocodone were less likely to take the painkiller if they used cannabis. [389]

That leaves those touting CBD’s effectiveness pointing primarily to research in mice and petri dishes. There, CBD (sometimes combined with small amounts of THC) has shown promise for helping pain, neurological conditions like anxiety and PTSD, and the immune system—and therefore potentially arthritis, diabetes, multiple sclerosis, cancer, and more.

In studying over 4,600 test subjects, researchers found that current cannabis users had fasting insulin levels that were up to 16 percent lower than their non-using counterparts, higher levels of HDL cholesterol that protects against diabetes, and 17 percent lower levels of insulin resistance. Respondents who had used cannabis in their lifetime but were not current users showed similar but less pronounced associations, indicating that the protective effect of cannabis fades with time.[180]
We have receptors for cannabinoids in the whole body, but the first type — CB1 — are very dense in the pain pathways of the brain, spine, and nerves. The second type — CB2 — is more important for the immune system but is also involved in inflammation. By gently acting on both pathways, our internal cannabinoids and CBD can balance both pain and inflammation [R+].
Best known for their role in beer brewing, the female flowers of hop are being increasingly used in supplements for insomnia, anxiety, and menopausal symptoms. In addition, research on their components has revealed new activities with promising clinical applications. Read below to learn more about hops’ components, health benefits, side effects, and interactions with drugs […]
A 2013 study that measured data from 4,652 participants on the effect of cannabis on metabolic systems compared non-users to current and former users. It found that current users had higher blood levels of high-density lipoprotein (HDL-C) or “good cholesterol.” The same year, an analysis of over seven hundred members of Canada’s Inuit community found that, on average, regular cannabis users had increased levels of HDL-C and slightly lower levels of LDL-C (“bad cholesterol”).
Numerous studies have found results that confirm the ability of marijuana to help anxiety and stress. In 2013 an Israeli study demonstrated that treatment with cannabinoids helped to control emotional responses and prevent stress-related responses for those that had experienced a traumatic experience. In 2015 a group of researchers found that cannabis treatments were effective in reducing anxiety in those suffering from PTSD.
Here’s another interesting fact for you: CBD has really strong anti-oxidant and anti-inflammatory properties, due primarily to its effects on your adenosine receptors and cytochrome P-450 and 2C enzymes. When this was first discovered, the US government insisted that cannabis had no medical benefits, but at the same time, they took out patent 6,630,507, which gave them rights to the antioxidant properties of cannabis (which they ironically still claim don’t exist). Incidentally, that patent was not extended to actual oil or capsule extracts of cannabis, so the good ol’ US gummint missed out on some pretty good business opportunities, if you ask me.
×